26 Feb 2017 | 4:52 PM
 

Syncom Formulation (India) Ltd. Share Price Live (BSE)
0

BSE Code: 524470 | NSE Symbol:
2.05
-0.01
(-0.48 %)
23 Feb 2017 | 04:01 PM
Change company
  • Open (Rs)
    2.05
  • Prev. close (Rs.)
    2.06
  • High (Rs.)
    2.08
  • Low (Rs.)
    2.03
  • 52W H (Rs.)
    3.49
  • 52W L (Rs.)
    1.87
  • Volume (Rs.)
    1234889
  • MCap (Rs in Cr.)
    160.04
  • Open (Rs)
  • High (Rs)
  • Low (Rs)
  • Prev. close(Rs)
  • Contracts Tra.
  • Turnover (Cr.)
  • Open Interest
  • Open Int. chg
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
0.13
Operating Margin (%)
9.02
Gross Profit Margin (%)
7.39
Net Profit Margin (%)
5.63
Total Debt/Equity
0.05
Dividend payout Ratio (Net Profit)
18.14
Earning Retention Ratio
82.04

News

16 Mar 2016 - 10:55:00-Syncom Formulations (India) engaged in the business of pharmaceutical formulations said that it has ...

Announcements

01-Feb-2017
Syncom Formul. - Board Meeting Intimation for Results
01-Feb-2017
Syncom Formul. - Closure of Trading Window
12-Jan-2017
Syncom Formul. - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended December
11-Jan-2017
Syncom Formul. - Shareholding for the Period Ended December 31 2016
15-Nov-2016
Syncom Formul. - Standalone Financial Results Limited Review Report for September 30 2016

Religare Research

23 Feb 2017 | 06:00 PM
This week, we haven’t initiated fresh position, keeping in mind overbought market conditions and num...
23 Feb 2017 | 06:00 PM
Nifty index settled on a positive note for the fifth successive week, hitting 52 week high on the la...
23 Feb 2017 | 12:45 PM
VIP Industries (VIP) reported in-line numbers for Q3FY17 with a revenue and PAT growth of 5.5% & 43....
23 Feb 2017 | 11:15 AM
Agri Fundamental report

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

      
Promotors41.22%
Mutual Funds/UTI0.00%
FI/Banks0.01%
Insurance0.01%
FII0.00%
Government0.00%
Others8.86%

Peer Group

Company Intraday Graph
 Kovai Medical Center and Hospital Ltd.
1,119.90(2.32)
11816
 Merck Ltd.
1,087.80(-0.35)
3302
 AstraZeneca Pharma India Ltd.
917.25(0.21)
3274
 Neuland Laboratories Ltd.
903.35(0.04)
3578

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Syncom Formulation (India) Ltd.0.15-0.01-0.71
NIFTY(S&P CNX)548.00906.20306.90
BSE SENSEX1,775.632,841.16902.76
BSE 500763.721,333.78587.62

Corporate Details

Key Personal
Kedarmal Bankda
Exe.Chairman & W T D
Rinki Ankit Bankda
Woman Director
Vijay Shankarlal Bankda
Managing Director
Key Address
Registered Office
7 Niraj Industrial Estate Off Mahakali Caves Road Andheri (East),Mumbai,Maharashtra

Tel:022-30887744 30887754 30887756, Fax:022-30887755

info@sfil.in
http://www.sfil.in
Registrar Office
Ankit Consultancy Pvt. Ltd.
Add. :Plot No. 60 Electronic Complex Pardeshipura

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Syncom Formulation (India) Ltd. that will help you decide whether to buy, sell or hold Syncom Formulation (India) Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Syncom Formulation (India) Ltd.